glp-1 receptor agonist patient assistance programs MCT2D A clinician's perspective 📝 GLP-1

Jung SA, Choi M, Kim S, Yu R, Park T

Pancreatitis risk associated with GLP-1 receptor agonists, considered as a single class, in a comorbidity-free subgroup of type 2 diabetes patients in the United States: a propensity score-matched analysis

GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces to help regulate blood sugar and appetite

alternative therapies may be preferred

The patients were divided into seven parallel trials that analyzed the risk of developing addictions to multiple substances including alcohol, cannabis, cocaine, nicotine and opioids

For peripapillary retinal nerve fiber layer (pRNFL) measurement, a 12 (3.4 mm) ring scan centered on the optic nerve head was used (1536 A-scans, automatic real-time tracking [ART]: 100 averaged frames) [22]